A Drug-Environment Interaction Between PM2.5 Concentration and Corticosteroid Use on Cardiovascular and Thromboembolic Events in Older Adults - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Interaction of PM2.5 Levels and Corticosteroid Administration on Cardiovascular and Thromboembolic Outcomes in Elderly Individuals

  • By

  • Shu-Ping Huang

  • Chien-Chou Su

  • Rachel Nethery

  • Kevin Josey

  • Benjamin Bates

  • David Robinson

  • Poonam Gandhi

  • Melanie Rua

  • Ashwaghosha Parthasarathi

  • Soko Setoguchi

  • Yea-huei Kao Yang

  • July 1, 2026

Share

  • 1

    Air pollution, particularly PM2.5, significantly impacts the elderly, increasing risks of cardiovascular and thromboembolic events.

  • 2

    Corticosteroids, commonly used for respiratory conditions, are linked to cardiovascular and thromboembolic events due to their effects on blood vessels.

  • 3

    The study utilizes Taiwan's National Health Insurance Database to evaluate the interaction between PM2.5 exposure and corticosteroid use.

  • 4

    The cohort includes high-risk patients with chronic conditions, such as atrial fibrillation and heart failure, from 2009 to 2019.

  • 5

    Seasonal average PM2.5 concentrations were calculated using data from 85 monitoring stations across Taiwan.

Original Source(s)

A Drug-Environment Interaction Between PM2.5 Concentration and Corticosteroid Use on Cardiovascular and Thromboembolic Events in Older Adults

  • by Shu-Ping Huang, Chien-Chou Su, Rachel Nethery, Kevin Josey, Benjamin Bates, David Robinson, Poonam Gandhi, Melanie Rua, Ashwaghosha Parthasarathi, Soko Setoguchi, Yea-huei Kao Yang

  • July 1, 2026

Related Content

Insulin resistance as a predictor of long-term adverse cardiovascular event risk in patients with atrial fibrillation following radiofrequency catheter ablation

P2Y12 Inhibitors and Mortality in Patients Hospitalized With Intracerebral Hemorrhage

Systemic immune-inflammation Index is an independent risk factor for Major adverse cardiovascular events in patients with coronary artery ectasia